Sean S.  Daugherty net worth and biography

Sean Daugherty Biography and Net Worth

Insider of Hologic
Sean Daugherty was promoted to Group President, Breast & Skeletal Health and GYN Surgical Solutions in August 2020. He joined Hologic in May 2017 as Vice President of Sales for the GYN Surgical division, and was promoted to President of the division in July 2017. He has more than 14 years of experience leading commercial operations, and has established a track record of growing revenue and EBITDA, improving the customer experience, and developing talented and highly engaged teams. Before joining Hologic, Mr. Daugherty served in leadership roles for several medical technology companies including Resmed and Stryker, where he began his career and held positions of increasing responsibility including General Manager, Patient Care, in Stryker’s Medical division. He holds a BS degree in Biological Aspects of Conservation from the University of Wisconsin, where he also was a captain of the basketball team.

How do I contact Sean S. Daugherty?

The corporate mailing address for Mr. Daugherty and other Hologic executives is 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752. Hologic can also be reached via phone at (508) 263-2900 and via email at [email protected]. Learn More on Sean S. Daugherty's contact information.

Has Sean S. Daugherty been buying or selling shares of Hologic?

Sean S. Daugherty has not been actively trading shares of Hologic over the course of the past ninety days. Learn More on Sean S. Daugherty's trading history.

Who are Hologic's active insiders?

Hologic's insider roster includes Benjamin Cohn (Insider), Sally Crawford (Director), Sean Daugherty (Insider), Scott Garrett (Director), John Griffin (General Counsel), Stephen Macmillan (CEO), Essex Mitchell (Insider), Karleen Oberton (CFO), Kevin Thornal (Insider), Peter Valenti, III (Insider), and Jan Verstreken (Insider). Learn More on Hologic's active insiders.

Are insiders buying or selling shares of Hologic?

During the last twelve months, insiders at the medical equipment provider sold shares 7 times. They sold a total of 62,736 shares worth more than $4,696,732.85. The most recent insider tranaction occured on March, 14th when Director Scott T Garrett sold 16,441 shares worth more than $1,241,295.50. Insiders at Hologic own 1.8% of the company. Learn More about insider trades at Hologic.

Information on this page was last updated on 3/14/2024.

Sean S. Daugherty Insider Trading History at Hologic

See Full Table

Sean S. Daugherty Buying and Selling Activity at Hologic

This chart shows Sean S. Daugherty's buying and selling at Hologic by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Hologic Company Overview

Hologic logo
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
Read More

Today's Range

Now: $77.96
Low: $77.09
High: $78.16

50 Day Range

MA: $74.82
Low: $72.04
High: $77.96

2 Week Range

Now: $77.96
Low: $64.02
High: $87.88

Volume

1,990,262 shs

Average Volume

1,745,822 shs

Market Capitalization

$18.30 billion

P/E Ratio

36.95

Dividend Yield

N/A

Beta

1